- $12.45m
- $3.86m
- $5.21m
U.S. STOCKS ON THE MOVE -Health insurers, Arista, Savara
Plus Therapeutics rises as it secures new billing code for cancer test
U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO
NASDAQ RESUMED AT 09:00 AM
NASDAQ RESUMED AT 04:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Plus Therapeutics Announces Reverse Stock Split
Plus Therapeutics 2025 net loss widens
Brief: Plus Therapeutics FY Net Income USD -22.386 Million
Brief: Plus Therapeutics Announces New Category III CPT Code
Brief: Plus Therapeutics To Provide Business Update On Thursday
Brief: Plus Therapeutics Inc - On Jan 13, Co Enters Underwriting Agreement With Lake Street Capital Markets, Llc - SEC Filing
Brief: Plus Therapeutics Announces Pricing Of Upsized $15 Million Public Offering
Brief: Plus Therapeutics Announces Read Out Of Type B Meeting With The FDA
U.S. RESEARCH ROUNDUP-Bath & Body Works, Elastic, Walmart
Brief: Plus Therapeutics Secures National Coverage Agreement With Humana For Cnside® Cerebrospinal Fluid Assay For Metastatic Cns Cancer
Plus Therapeutics Q3 net loss widens